Literature DB >> 23054026

Functional polymorphisms in PIN1 promoter and esophageal carcinoma susceptibility in Chinese population.

Yonghe You1, Jieqiong Deng, Jian Zheng, Lan Jiang, Na Li, Hongchun Wu, Wei Li, Jiachun Lu, Yifeng Zhou, Bin Ni.   

Abstract

Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (PIN1), which regulates the conformation of Pro-directed phosphorylation sites, has been identified as a critical catalyst involved in multiple oncogenic signaling pathways. Recently, it has been demonstrated that several putative functional polymorphisms of PIN1 gene were associated with cancer risk. This study examined whether genetic polymorphisms in promoter of PIN1 are associated with esophageal carcinoma susceptibility. Two common polymorphisms in PIN1, rs2233678 (-842G>C) and rs2233679 (-667C>T) were genotyped in this hospital-based case-control study of 699 esophageal carcinoma patients and 729 healthy controls. The results revealed that compared with the most common -842GG genotype carriers, the carriers of -842C variant genotypes (GC+CC) had significantly decreased risk of esophageal carcinoma [odds ratio (OR) = 0.55, 95 % CI = (0.40-0.75), P = 0.001]. No association was observed between the -667C>T polymorphism and the risk of esophageal carcinoma. Furthermore, we found that the haplotype of 'C(-842)-C(-667)' had a greater protected effect [OR = 0.67, 95 % CI = (0.47-0.96), P = 0.021]. Functional assay revealed that -842C variant genotypes (GC+CC) carriers had a lower transcription activity and mRNA expression level than the -842GG carriers. These results indicated that -842G>C genetic variant in PIN1 promoter may decrease the promoter activity, resulting in changes in the levels of PIN1 and modifying cancer susceptibility.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23054026     DOI: 10.1007/s11033-012-2122-x

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  41 in total

1.  Interactions between protein kinase CK2 and Pin1. Evidence for phosphorylation-dependent interactions.

Authors:  Moira M Messenger; Ronald B Saulnier; Andrew D Gilchrist; Phaedra Diamond; Gary J Gorbsky; David W Litchfield
Journal:  J Biol Chem       Date:  2002-04-08       Impact factor: 5.157

Review 2.  Oncogenic kinase signalling.

Authors:  P Blume-Jensen; T Hunter
Journal:  Nature       Date:  2001-05-17       Impact factor: 49.962

3.  Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1.

Authors:  G M Wulf; A Ryo; G G Wulf; S W Lee; T Niu; V Petkova; K P Lu
Journal:  EMBO J       Date:  2001-07-02       Impact factor: 11.598

4.  Pin1 promoter polymorphisms in hepatocellular carcinoma patients.

Authors:  Ludovica Segat; Michele Milanese; Sergio Crovella
Journal:  Gastroenterology       Date:  2007-06       Impact factor: 22.682

Review 5.  Phosphorylation-specific prolyl isomerization: is there an underlying theme?

Authors:  Gerburg Wulf; Greg Finn; Futoshi Suizu; Kun Ping Lu
Journal:  Nat Cell Biol       Date:  2005-05       Impact factor: 28.824

6.  The polymorphism and haplotypes of PIN1 gene are associated with the risk of lung cancer in Southern and Eastern Chinese populations.

Authors:  Jiachun Lu; Lei Yang; Hongjun Zhao; Bin Liu; Yinyan Li; Hongxia Wu; Qingchu Li; Bohang Zeng; Yunnan Wang; Weidong Ji; Yifeng Zhou
Journal:  Hum Mutat       Date:  2011-09-19       Impact factor: 4.878

7.  The prolyl isomerase Pin1 is a novel prognostic marker in human prostate cancer.

Authors:  Gustavo Ayala; Dagong Wang; Gerburg Wulf; Anna Frolov; Rile Li; Janusz Sowadski; Thomas M Wheeler; Kun Ping Lu; Lere Bao
Journal:  Cancer Res       Date:  2003-10-01       Impact factor: 12.701

8.  Prevalent overexpression of prolyl isomerase Pin1 in human cancers.

Authors:  Lere Bao; Amy Kimzey; Guido Sauter; Janusz M Sowadski; Kun Ping Lu; Da-Gong Wang
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

9.  The Axin1 scaffold protein promotes formation of a degradation complex for c-Myc.

Authors:  Hugh K Arnold; Xiaoli Zhang; Colin J Daniel; Deanne Tibbitts; Julie Escamilla-Powers; Amy Farrell; Sara Tokarz; Charlie Morgan; Rosalie C Sears
Journal:  EMBO J       Date:  2009-01-08       Impact factor: 11.598

Review 10.  The prolyl isomerase Pin1 in breast development and cancer.

Authors:  Gerburg Wulf; Akihide Ryo; Yih-Cherng Liou; Kun Ping Lu
Journal:  Breast Cancer Res       Date:  2003-01-28       Impact factor: 6.466

View more
  11 in total

1.  Association of rs2233678 and rs2233679 polymorphisms in the PIN1 gene with cancer risk: a meta-analysis.

Authors:  Li Zhenzhen; Sun Ning; Liu Xianghua
Journal:  Tumour Biol       Date:  2013-08-28

2.  PIN1 genetic polymorphisms and the susceptibility of HBV-related hepatocellular carcinoma in a Guangxi population.

Authors:  Li Huang; Zhuning Mo; Xianjun Lao; Xiaolian Zhang; Yanqiong Liu; Jingzhe Sui; Xue Qin; Shan Li
Journal:  Tumour Biol       Date:  2015-12-07

3.  Lack of association between the PIN1 promoter -667T>C (rs2233679) polymorphism and cancer risk: Evidence from meta-analysis.

Authors:  Liangjun Tao; Yisheng Chen; Lingsong Tao; Jian Kong; Haibo Qin; Jie Zheng; Bin Zou; Sizhong He
Journal:  Biomed Rep       Date:  2014-01-22

4.  The -842G/C polymorphisms of PIN1 contributes to cancer risk: a meta-analysis of 10 case-control studies.

Authors:  Hui-Rong Xu; Zhong-Fa Xu; Yan-Lai Sun; Jian-Jun Han; Zeng-Jun Li
Journal:  PLoS One       Date:  2013-08-27       Impact factor: 3.240

5.  Single nucleotide polymorphisms of PIN1 promoter region and cancer risk: evidence from a meta-analysis.

Authors:  Jing-Jing Peng; Dong Wei; Dong Li; Zeng-Qiang Fu; Yong Tan; Tao Xu; Jing-Jun Zhou; Tao Zhang
Journal:  PLoS One       Date:  2013-08-16       Impact factor: 3.240

6.  PIN1 promoter polymorphism (-842 G>C) contributes to a decreased risk of cancer: Evidence from meta-analysis.

Authors:  Liang-Jun Tao; Yi-Sheng Chen; Lei Yao; Bin Zou; Ling-Song Tao; Jian Kong; Ying-Qing Liu; Qiang Cao; Chang-Jun Yin
Journal:  Oncol Lett       Date:  2014-06-24       Impact factor: 2.967

7.  The association between PIN1 genetic polymorphisms and the risk of chronic hepatitis B and hepatitis B virus-related liver cirrhosis: A case-control study.

Authors:  Li Huang; Zhuning Mo; Shan Li; Xue Qin
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

8.  A Guide to PIN1 Function and Mutations Across Cancers.

Authors:  Maguie El Boustani; Lucia De Stefano; Isabella Caligiuri; Nayla Mouawad; Carlotta Granchi; Vincenzo Canzonieri; Tiziano Tuccinardi; Antonio Giordano; Flavio Rizzolio
Journal:  Front Pharmacol       Date:  2019-01-22       Impact factor: 5.810

9.  The rs2233678 polymorphism in PIN1 promoter region reduced cancer risk: a meta-analysis.

Authors:  Qi Li; Zhao Dong; Yun Lin; Xinyan Jia; Qun Li; Hong Jiang; Liwei Wang; Yong Gao
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240

10.  Functional PIN1 promoter polymorphisms associated with risk of nasopharyngeal carcinoma in Southern Chinese populations.

Authors:  Liuyan Zeng; Shengqun Luo; Xin Li; Mengxuan Lu; Huahui Li; Tong Li; Guanhua Wang; Xiaoming Lyu; Wenrui Jia; Zigang Dong; Qiang Jiang; Zhihua Shen; Guo-Liang Huang; Zhiwei He
Journal:  Sci Rep       Date:  2017-07-04       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.